| 查看: 494 | 回复: 0 | |||
[交流]
尘螨过敏的过敏性鼻炎患者舌下脱敏起效时间：随机双盲安慰剂对照试验
|
|
Objectives/Hypothesis: To investigate how quickly an allergic rhinitis (AR) patients’ symptoms will improve with sublingual immunotherapy (SLIT). Study Design: Double-blind placebo study. Methods: This is a multicenter, randomized, double-blind, placebo-controlled study of SLIT used to treat house dust mite-induced AR. A total of 120 AR patients, aged 4 to 60 years, were treated for 6 months and randomized into two groups:1) SLIT with Dermatophagoides pteronyssinus (D.p.) and Dermatophagoides farina (D.f.) extract (n 5 60) ; and 2) matched placebo controls (n 5 60). Symptom, medications received, and a visual analog scale score were recorded during the whole study. Serum-specific IgE and IgG4 to D. p. and D. f. were assessed before and after the treatment. Results: Eighty-five patients (70.8%) completed the study. Twelve patients (20%) chose to withdraw from the SLIT group, but none because of serious adverse effects. The total symptom and visual analog scores VAS in the SLIT group decreased significantly when compared to the placebo controls (P <0.05) after week 14, as well as for the significant (P <0.05) improvement of all individual AR symptoms in the SLIT group (e.g., sneezing, nasal discharge, itching, and nasal obstruction) after week 22. There was a significant (P <0.05) increase of IgG4 to both D.f. and D.p. in the SLIT, but not in the placebo group after treatment. Conclusion: SLIT with a mixture of D.f. and D.p. extract is an effective and safe treatment for patients with house dust mite-induced AR. Its onset of action can be observed as early as 14 weeks after treatment. |
回复此楼» 猜你喜欢
求调剂
已经有1人回复
-
求问即时影响因子的计算方式是这样么？
已经有3人回复
-
放射医学论文润色/翻译怎么收费?
已经有116人回复
-
医学口的还查不到？
已经有10人回复
-
硅溶胶，铝溶胶和钛溶胶
已经有5人回复